20 November 2019 - Coagulation Analyzers and Reagents Market
size was worth USD 3.3 billion in 2015 and is likely to grow at a CAGR of over
10.2% over the forecast period. The growth of this market is supported by
increasing number of lifestyle disorders and chronic blood related disorders.
The increase in the volume of testing can be attributed to
the augmented awareness among people towards lifestyle and blood disorders
which is expected to further improve the diagnostic rate and preventive care
management. The study covers developing countries which are undergoing paradigm
shift and are highly investing government funds for the procurement and
installation of these medical devices in the public healthcare facilities.
Request a PDF Sample
@ https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market/request-sample
Specifically, for the developing nations of the Asia Pacific
and Middle East region factors such as increased geriatric population, rapid
growth in foreign investments and rising prevalence of lifestyle disorders are
expected to be support market growth. Another major driving force identified is
the increased incidence of haemophilia as per a report published by the WHO,
resulting in the industry growth and rising installation base and expansion of
these medical devices in the healthcare facilities.
Product Insights
Analyzers are one of the most critical and important equipment
used for diagnosis, currently owing to multiple factors and thus are expected
to have a lucrative CAGR in the forecasted period. The major factors driving
the growth of this segment are increasing incidences of the lifestyle disorders
such as diabetes, cardiovascular disorders and obesity combined with developing
healthcare infrastructure and spending on healthcare.
The factor expected to propel the growth of the diagnostics
market, are providing timely and quality care to the patients which in turn is expected
to hike the demand for hemostasis analyzers. The class of hemostasis analyzers
recording the majority of the shares in 2015 is the clinical laboratory
analyzers which are predominantly used in the hospitals for the hematological
analysis of the patients on a daily basis.
Shares up to 65.0% were held by the Consumables segments
which were further sub segmented to stains and reagents. Due to the pre
requisite of having reagents for each and every test, their demand also
increases with increase in diagnostic volume, hence a high repository of orders
are placed by the hospitals. The sales of these consumables are expected to be
boosted by the higher volumes of testing and development of new and innovative
assays.
Technological
Insights
Over the period of forecast, optical technology is estimated
to hold majority of the shares due to the increasing combination of photo
optical method with immunologics and chromogenics. This combination has led to
the development of multipurpose, high performance optical hemostasis analyzers.
This segment is further divided into
chromogenic/immunological/photo optical and others. The other segment includes
technologies that are patented by Beckman Coulter Inc., Instrumentation
Laboratory, Siemens Healthcare and others.
Market Segment:
Product Outlook
(Revenue, USD Million, 2013 - 2024)
• Analyzers
•
Clinical Laboratory Analyzers
•
Point of Care Analyzers
• Consumables
•
Reagents
•
Stains
Technology Outlook
(Revenue, USD Million, 2013 - 2024)
• Mechanical
•
Electrochemical
• Optical
•
Photo optical/Chromogenic/Immuno
•
Others/Nephelometric
• Others
For More Technical
Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/coagulation-analyzers-reagents-market
Major players in the market are namely Siemens Healthcare,
Instrumentation Laboratory, and Roche Diagnostics, Alere, Inc., Thermo Fischer
Scientific, and Nihon Kohden. Due to the easy global accessibility in this
market, the major players are already present in across various countries and
are competing to secure the higher market share.
Distributions of these products are majorly done by third
party vendors presently. For example, Sysmex entered into an agreement with
Dade Behring for the distribution of their products, which is now a part of
Siemens Healthcare Diagnostics. But on the contrary this trend is expected to
change in the forecasted period due to the increase in the investment to
establish offices for distribution within multiple regions by the players
leading to the rise in the momentum of direct supply agreements in the regions
over the period of forecast.
No comments:
Post a Comment